An affiliate of GlaxoSmithKline plc, GlaxoSmithKline Consumer Nigeria Plc (GSK Nigeria) board has approved a change in its supply chain model effective Q3 2021. Following an extensive review of its product supply operation, the Board of Directors has approved a restructuring of GSK’s current op
```
Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```

Join BusinessDay whatsapp Channel, to stay up to date

Open In Whatsapp